Ardsley Advisory Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-150,000
Closed -$9.41M 161
2026
Q1
$9.41M Buy
+150,000
New +$12M 1.2% 24
2023
Q4
Sell
-101,650
Closed -$5.37M 143
2023
Q3
$5.37M Buy
+101,650
New +$5.33M 1.2% 27
2020
Q4
Sell
-37,250
Closed -$1.42M 145
2020
Q3
$1.42M Buy
37,250
+26,250
+239% +$1.01M 0.27% 53
2020
Q2
$386K Buy
+11,000
New +$396K 0.08% 93
2020
Q1
Sell
-27,500
Closed -$1.24M 116
2019
Q4
$1.24M Buy
27,500
+500
+2% +$20.9K 0.2% 64
2019
Q3
$1.1M Sell
27,000
-6,000
-18% -$254K 0.25% 62
2019
Q2
$1.42M Buy
33,000
+10,500
+47% +$404K 0.22% 57
2019
Q1
$864K Buy
22,500
+2,500
+13% +$95.5K 0.17% 60
2018
Q4
$707K Buy
20,000
+7,500
+60% +$272K 0.18% 55
2018
Q3
$481K Buy
12,500
+2,500
+25% +$87.3K 0.06% 109
2018
Q2
$327K Sell
10,000
-10,000
-50% -$302K 0.05% 134
2018
Q1
$547K Hold
20,000
0.08% 95
2017
Q4
$496K Buy
+20,000
New +$552K 0.06% 93
2017
Q1
Sell
-10,000
Closed -$216K 156
2016
Q4
$216K Sell
10,000
-2,500
-20% -$54.5K 0.04% 114
2016
Q3
$298K Buy
+12,500
New +$298K 0.05% 113
2015
Q4
Sell
-15,000
Closed -$246K 146
2015
Q3
$246K Buy
+15,000
New +$256K 0.06% 115
2015
Q1
Sell
-15,000
Closed -$199K 197
2014
Q4
$199K Sell
15,000
-10,000
-40% -$128K 0.03% 166
2014
Q3
$295K Sell
25,000
-5,000
-17% -$63K 0.04% 148
2014
Q2
$383K Buy
30,000
+5,000
+20% +$65K 0.05% 184
2014
Q1
$338K Buy
25,000
+10,000
+67% +$131K 0.05% 171
2013
Q4
$180K Buy
+15,000
New +$177K 0.02% 146

Other funds holding BSX

Ardsley Advisory Partners's BSX Position: Q2 2026 in Review

Ardsley Advisory Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 150,000 shares — an estimated $9.41M sold.

Ardsley Advisory Partners first reported a position in BSX in Q4 2013 and held it in 21 quarters. The position peaked at $9.41M in Q1 2026. 425 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Ardsley Advisory Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Ardsley Advisory Partners sold 150,000 Boston Scientific shares in Q2 2026, an estimated $9.41M.
  • Ardsley Advisory Partners first reported a position in Boston Scientific in Q4 2013 and held it in 21 quarters.
  • Ardsley Advisory Partners's Boston Scientific position peaked at $9.41M in Q1 2026.
  • 425 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Ardsley Advisory Partners's 13F filing for Q2 2026, filed 13 Jul 2026.